![](/img/cover-not-exists.png)
Phase II APEC trial: The impact of primary tumor side on outcomes of first‐line cetuximab plus FOLFOX or FOLFIRI in patients with RAS wild‐type metastatic colorectal cancer
Price, Timothy, Shen, Lin, Ma, Brigette, Esser, Regina, Chen, Wenfeng, Gibbs, Peter, Lim, Robert, Cheng, Ann‐LiiLanguage:
english
Journal:
Asia-Pacific Journal of Clinical Oncology
DOI:
10.1111/ajco.13154
Date:
May, 2019
File:
PDF, 542 KB
english, 2019